Active substance
Aluminium hydroxide
- SFDA 1
- US price lines 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ALUGEL SUSP | 64 mg/ml | Oral suspension · Oral use | 1 Bottle | SAR 4.05 | NCE · OTC | Hikma Pharmaceuticals PLC | Withdrawn by MAH · Not Marketed |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | ALUMINUM HYDROXIDE GEL | $0.01327 | per ML | 22 Jul 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Combinations containing Aluminium hydroxide
- Aluminium hydroxide + magnesium hydroxide
- Aluminium hydroxide + magnesium trisilicate
- Aluminium hydroxide + calcium chloride + menthol
- Aluminium hydroxide + magnesium carbonate + magnesium hydroxide
- Aluminium hydroxide + magnesium hydroxide + oxethazaine
- Aluminium hydroxide + magnesium hydroxide + oxethazine
- Aluminium hydroxide + magnesium hydroxide + simeticone
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.